Bleeding risk in patients with cardiac disease from ischaemic stroke reperfusion therapy: an update

BACKGROUND: Intravenous tissue plasminogen activator (rtPA) and arterial endovascular therapy (ET) rapidly restore cerebral perfusion in eligible patients who had an acute ischaemic stroke (AIS). It is unknown whether patients who had an AIS with premorbid cardiac disease respond differently to repe...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Bridget J, Daneshvari, Nicholas O, Johansen, Michelle C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372809/
https://www.ncbi.nlm.nih.gov/pubmed/34485911
http://dx.doi.org/10.1136/bmjno-2021-000156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372809/
https://www.ncbi.nlm.nih.gov/pubmed/34485911
http://dx.doi.org/10.1136/bmjno-2021-000156

Ejemplares similares